Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig06801 |
member ras oncogene family |
471 |
20 |
3.57E-52 |
90.40% |
10 |
F:GTP binding; C:Golgi apparatus; C:late endosome; C:plasma membrane; C:lysosome; F:protein transporter activity; P:bone resorption; P:intracellular protein transport; P:small GTPase mediated signal transduction; F:GTPase activity |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig06802 |
haus augmin-like subunit 6 |
129 |
3 |
3.98E-11 |
83.67% |
2 |
P:P; C:C |
|
|
contig06803 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig06804 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
contig06805 |
tho complex 2 |
233 |
20 |
6.40E-17 |
80.65% |
2 |
P:transport; P:RNA processing |
|
|
contig06806 |
---NA--- |
245 |
0 |
|
|
0 |
|
|
|
contig06807 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
contig06808 |
wd repeat phosphoinositide interacting 2 |
383 |
20 |
1.23E-44 |
90.70% |
1 |
C:protein complex |
|
|
contig06809 |
nicolin 1 |
565 |
20 |
1.34E-34 |
67.30% |
1 |
C:intracellular organelle |
|
|
contig06810 |
phosphodiesterase 7b |
252 |
18 |
1.45E-12 |
68.89% |
6 |
P:synaptic transmission; F:hydrolase activity; F:catalytic activity; F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; P:signal transduction |
|
|
contig06811 |
myosin vii |
243 |
19 |
4.68E-12 |
79.47% |
13 |
P:imaginal disc-derived wing hair organization; C:myosin complex; F:ATP binding; P:antennal morphogenesis; F:motor activity; F:actin-dependent ATPase activity; F:actin binding; F:transporter activity; P:sensory perception of sound; P:bristle morphogenesis; C:cytoplasm; P:actin filament-based movement; F:myosin light chain binding |
|
|
contig06812 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
contig06813 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig06814 |
single-stranded dna binding protein 1 |
322 |
20 |
2.67E-39 |
84.20% |
3 |
F:single-stranded DNA binding; C:mitochondrion; P:DNA replication |
|
|
contig06815 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
contig06816 |
---NA--- |
292 |
0 |
|
|
0 |
|
|
|
contig06817 |
---NA--- |
436 |
0 |
|
|
0 |
|
|
|
contig06818 |
---NA--- |
233 |
0 |
|
|
0 |
|
|
|
contig06819 |
---NA--- |
267 |
0 |
|
|
0 |
|
|
|
contig06820 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig06821 |
---NA--- |
273 |
0 |
|
|
0 |
|
|
|
contig06822 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
contig06823 |
cezanne 2 protein |
247 |
16 |
1.55E-15 |
75.44% |
1 |
F:binding |
|
|
contig06824 |
---NA--- |
266 |
0 |
|
|
0 |
|
|
|
contig06825 |
o-6-methylguanine-dna methyltransferase |
221 |
20 |
2.46E-24 |
81.05% |
6 |
F:DNA binding; F:methylated-DNA-[protein]-cysteine S-methyltransferase activity; C:nucleus; F:zinc ion binding; P:DNA dealkylation; P:regulation of caspase activity |
EC:2.1.1.63 |
|
contig06826 |
---NA--- |
106 |
0 |
|
|
0 |
|
|
|
contig06827 |
---NA--- |
266 |
0 |
|
|
0 |
|
|
|
contig06828 |
tudor domain containing 3 |
262 |
20 |
6.39E-33 |
87.50% |
1 |
F:nucleic acid binding |
|
|
contig06829 |
n-acetylneuraminic acid synthase |
1019 |
20 |
1.66E-134 |
88.65% |
6 |
P:lipopolysaccharide biosynthetic process; ; F:N-acylneuraminate cytidylyltransferase activity; F:N-acylneuraminate-9-phosphate synthase activity; C:cytosol; F:N-acetylneuraminate synthase activity |
EC:2.7.7.43; EC:2.5.1.57; EC:2.5.1.56 |
|
contig06830 |
kelch repeat and btb domain containing 1 |
223 |
20 |
8.70E-30 |
83.15% |
1 |
F:protein binding |
|
|
contig06831 |
suppressor of ty 5 homolog |
251 |
20 |
6.44E-38 |
95.65% |
9 |
P:neuron migration; P:positive regulation of transcription from RNA polymerase II promoter; F:enzyme binding; F:positive transcription elongation factor activity; F:negative transcription elongation factor activity; P:RNA elongation from RNA polymerase II promoter; P:transcription antitermination; F:protein heterodimerization activity; C:nucleus |
|
|
contig06832 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
contig06833 |
---NA--- |
275 |
0 |
|
|
0 |
|
|
|
contig06834 |
capn8 protein |
221 |
20 |
1.82E-19 |
73.40% |
9 |
F:cytoskeletal protein binding; C:insoluble fraction; F:calcium ion binding; P:protein autoprocessing; P:proteolysis; F:calcium-dependent cysteine-type endopeptidase activity; P:blastocyst development; P:myoblast fusion; C:cytoplasm |
|
|
contig06835 |
sec14 and spectrin domains 1 |
436 |
20 |
4.62E-52 |
81.65% |
0 |
|
|
|
contig06836 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig06837 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
contig06838 |
lamin b2 |
211 |
20 |
6.11E-12 |
87.75% |
2 |
C:lamin filament; F:structural molecule activity |
|
|
contig06839 |
---NA--- |
257 |
0 |
|
|
0 |
|
|
|
contig06840 |
---NA--- |
328 |
0 |
|
|
0 |
|
|
|
contig06841 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
contig06842 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
contig06843 |
---NA--- |
271 |
0 |
|
|
0 |
|
|
|
contig06844 |
ubiquitin-conjugating enzyme e2q |
246 |
20 |
3.00E-35 |
98.60% |
5 |
C:cytoplasm; P:ubiquitin cycle; F:ATP binding; F:ubiquitin-protein ligase activity; P:regulation of protein metabolic process |
EC:6.3.2.19 |
|
contig06845 |
---NA--- |
226 |
0 |
|
|
0 |
|
|
|
contig06846 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
contig06847 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig06848 |
---NA--- |
258 |
0 |
|
|
0 |
|
|
|
contig06849 |
solute carrier family member 43 |
254 |
20 |
6.06E-23 |
78.75% |
4 |
C:mitochondrial inner membrane; P:transport; C:membrane attack complex; F:transporter activity |
|
|
contig06850 |
---NA--- |
242 |
0 |
|
|
0 |
|
|
|
contig06851 |
---NA--- |
284 |
0 |
|
|
0 |
|
|
|
contig06852 |
kelch-like mayven |
243 |
20 |
1.00E-38 |
94.45% |
3 |
F:actin binding; F:protein homodimerization activity; C:stress fiber |
|
|
contig06853 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
contig06854 |
ddb2 protein |
453 |
20 |
3.22E-53 |
71.25% |
1 |
P:pyrimidine dimer repair |
|
|
contig06855 |
---NA--- |
332 |
0 |
|
|
0 |
|
|
|
contig06856 |
protein phosphatase regulatory subunit 13b |
258 |
20 |
1.06E-35 |
67.60% |
5 |
C:cytoplasm; P:induction of apoptosis; F:protein binding; C:nucleus; P:negative regulation of cell cycle |
|
|
contig06857 |
---NA--- |
172 |
0 |
|
|
0 |
|
|
|
contig06858 |
---NA--- |
230 |
0 |
|
|
0 |
|
|
|
contig06859 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
contig06860 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
contig06861 |
---NA--- |
289 |
0 |
|
|
0 |
|
|
|
contig06862 |
---NA--- |
283 |
0 |
|
|
0 |
|
|
|
contig06863 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
contig06864 |
---NA--- |
249 |
0 |
|
|
0 |
|
|
|
contig06865 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
contig06866 |
calcitonin gene-related peptide-receptor component protein |
291 |
20 |
1.16E-34 |
90.70% |
11 |
F:DNA-directed RNA polymerase activity; P:inflammatory response; P:acrosome reaction; C:acrosomal vesicle; F:nucleotide binding; F:calcitonin gene-related polypeptide receptor activity; P:transcription; P:neuropeptide signaling pathway; C:nucleus; C:plasma membrane; F:calcitonin receptor activity |
EC:2.7.7.6 |
|
contig06867 |
ubiquitin specific peptidase x- isoform 1 |
249 |
20 |
1.64E-33 |
98.60% |
5 |
C:cytoplasm; P:ubiquitin-dependent protein catabolic process; F:ubiquitin thiolesterase activity; P:ubiquitin cycle; F:endopeptidase inhibitor activity |
EC:3.1.2.15 |
|
contig06868 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig06869 |
unc-50 homolog |
248 |
20 |
3.21E-37 |
88.60% |
6 |
C:Golgi membrane; F:RNA binding; C:membrane attack complex; P:cell surface receptor linked signaling pathway; C:nuclear inner membrane; P:protein transport |
|
|
contig06870 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig06871 |
---NA--- |
114 |
0 |
|
|
0 |
|
|
|
contig06872 |
deah (asp-glu-ala-his) box polypeptide 37 |
244 |
20 |
8.21E-33 |
80.45% |
4 |
F:hydrolase activity; F:ATP binding; F:nucleic acid binding; F:helicase activity |
|
|
contig06873 |
---NA--- |
276 |
0 |
|
|
0 |
|
|
|
contig06874 |
---NA--- |
275 |
0 |
|
|
0 |
|
|
|
contig06875 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig06876 |
---NA--- |
249 |
0 |
|
|
0 |
|
|
|
contig06877 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig06878 |
---NA--- |
274 |
0 |
|
|
0 |
|
|
|
contig06879 |
---NA--- |
249 |
0 |
|
|
0 |
|
|
|
contig06880 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
contig06881 |
mgc89452 protein |
382 |
20 |
5.16E-43 |
83.00% |
2 |
P:P; C:C |
|
|
contig06882 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
contig06883 |
nucleoporin 50kda |
270 |
20 |
1.85E-16 |
94.55% |
2 |
P:intracellular transport; C:membrane |
|
|
contig06884 |
tmc7 protein |
241 |
20 |
6.57E-29 |
82.60% |
1 |
C:integral to membrane |
|
|
contig06885 |
transferrin |
217 |
20 |
1.58E-36 |
72.35% |
2 |
F:iron ion binding; P:ion transport |
|
|
contig06886 |
chromatin modifying protein 4b |
258 |
20 |
1.10E-08 |
91.90% |
2 |
P:protein transport; C:cytoplasm |
|
|
contig06887 |
unnamed protein product [Tetraodon nigroviridis] |
458 |
20 |
5.13E-35 |
52.30% |
1 |
F:F |
|
|
contig06888 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig06889 |
---NA--- |
139 |
0 |
|
|
0 |
|
|
|
contig06890 |
---NA--- |
203 |
0 |
|
|
0 |
|
|
|
contig06891 |
mitochondrial ribosomal protein 63 |
177 |
15 |
6.07E-20 |
80.07% |
2 |
C:mitochondrial ribosome; F:structural constituent of ribosome |
|
|
contig06892 |
von willebrand factor type egf and pentraxin domain containing 1 |
252 |
20 |
1.75E-38 |
82.05% |
7 |
C:extracellular region; C:membrane; C:cytoplasm; P:cell adhesion; F:calcium ion binding; F:protein binding; F:chromatin binding |
|
|
contig06893 |
---NA--- |
354 |
0 |
|
|
0 |
|
|
|
contig06894 |
unnamed protein product [Tetraodon nigroviridis] |
248 |
1 |
1.11E-05 |
81.00% |
0 |
|
|
|
contig06895 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
contig06896 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig06897 |
fc fragment of binding protein |
245 |
20 |
1.96E-18 |
65.10% |
2 |
P:cell adhesion; P:binding of sperm to zona pellucida |
|
|
contig06898 |
heat shock protein 1 |
341 |
20 |
2.31E-11 |
92.95% |
26 |
C:membrane raft; P:response to lipopolysaccharide; F:chaperone binding; P:protein folding; P:response to hydrogen peroxide; F:insulin binding; C:mitochondrial matrix; P:response to ATP; C:secretory granule; C:mitochondrial inner membrane; P:response to estrogen stimulus; C:Golgi apparatus; P:fin regeneration; P:positive regulation of anti-apoptosis; C:cytosol; F:protein heterodimerization activity; P:response to hypoxia; F:unfolded protein binding; P:response to drug; F:protease binding; P:response to heat; P:positive regulation of inflammatory response; C:cyclin-dependent protein kinase activating kinase holoenzyme complex; C:rough endoplasmic reticulum; F:ATP binding; P:response to cocaine |
|
|
contig06899 |
---NA--- |
290 |
0 |
|
|
0 |
|
|
|
contig06900 |
---NA--- |
476 |
0 |
|
|
0 |
|
|
|
100 Rows returned.